A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial

Group Comparison ◽

Double Blind ◽

Parallel Group ◽

Comparison Trial

Rationale, Design, and Methods of the Study of Comparison of Canagliflozin vs. Teneligliptin Against Basic Metabolic Risks in Patients with Type 2 Diabetes Mellitus (CANTABILE study): Protocol for a Randomized, Parallel-Group Comparison Trial

Diabetes Therapy ◽

10.1007/s13300-019-00717-9 ◽

2019 ◽

Vol 11 (1) ◽

pp. 347-358

Author(s):

Cheol Son ◽

Masato Kasahara ◽

Tomohiro Tanaka ◽

Noriko Satoh-Asahara ◽

Toru Kusakabe ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Study Protocol ◽

Group Comparison ◽

Parallel Group ◽

Comparison Trial ◽

Design And Methods

A randomized, double-blind, controlled, parallel-group comparison of perindopril and candesartan in hypertensive patients with type 2 diabetes mellitus

10.1016/s0149-2918(03)80201-1 ◽

2003 ◽

Vol 25 (7) ◽

pp. 2006-2021 ◽

Cited By ~ 17

Author(s):

Giuseppe Derosa ◽

Arrigo F.G. Cicero ◽

Leonardina Ciccarelli ◽

Roberto Fogari

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Group Comparison ◽

Double Blind ◽

Hypertensive Patients ◽

Sustained-release versus immediate-release glipizide for treatment of type 2 diabetes mellitus in chinese patients: A randomized, double-blind, double-dummy, parallel-group, 12-week clinical study

10.1016/j.clinthera.2006.09.010 ◽

2006 ◽

Vol 28 (9) ◽

pp. 1318-1326 ◽

Cited By ~ 4

Author(s):

Sheng-Hwu Hsieh ◽

Jen-Der Lin ◽

Hung-Yu Cheng ◽

Cheng Ho ◽

Miaw-Jene Liou

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Clinical Study ◽

Immediate Release ◽

Chinese Patients ◽

Double Blind ◽

Parallel Group ◽

Group 12

Efficacy and safety of pioglitazone added to alogliptin in Japanese patients with type 2 diabetes mellitus: a multicentre, randomized, double-blind, parallel-group, comparative study

Diabetes Obesity and Metabolism ◽

10.1111/dom.12555 ◽

2015 ◽

Vol 17 (12) ◽

pp. 1198-1201 ◽

Cited By ~ 5

Author(s):

K. Kaku ◽

M. Katou ◽

M. Igeta ◽

T. Ohira ◽

H. Sano

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Comparative Study ◽

Japanese Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Efficacy and safety of alogliptin in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, dose-ranging comparison with placebo, followed by a long-term extension study

Current Medical Research and Opinion ◽

10.1185/03007995.2011.599371 ◽

2011 ◽

Vol 27 (9) ◽

pp. 1781-1792 ◽

Cited By ~ 57

Author(s):

Yutaka Seino ◽

Tetsuya Fujita ◽

Shinzo Hiroi ◽

Masashi Hirayama ◽

Kohei Kaku

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Japanese Patients ◽

Extension Study ◽

Efficacy And Safety ◽

Double Blind ◽

Dose Ranging

Effects of pioglitazone and glimepiride on glycemic control and insulin sensitivity in Mexican patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, parallel-group trial

10.1016/s0149-2918(04)90068-9 ◽

2004 ◽

Vol 26 (5) ◽

pp. 680-693 ◽

Cited By ~ 42

Author(s):

Meng Tan ◽

Don Johns ◽

Guillermo González Gálvez ◽

Oscar Antúnez ◽

Guadalupe Fabián ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Insulin Sensitivity ◽

Glycemic Control ◽

Double Blind ◽

Parallel Group ◽

Parallel Group Trial ◽

Group Trial

Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: Results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group study

10.1016/j.clinthera.2005.05.005 ◽

2005 ◽

Vol 27 (5) ◽

pp. 554-567 ◽

Cited By ~ 70

Author(s):

Vinod Mattoo ◽

David Eckland ◽

Mario Widel ◽

Santiago Duran ◽

Carmen Fajardo ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Insulin Therapy ◽

Metabolic Effects ◽

Double Blind ◽

Parallel Group Study ◽

Effect of switching from pioglitazone to the sodium glucose co-transporter-2 inhibitor dapagliflozin on body weight and metabolism-related factors in patients with type 2 diabetes mellitus: An open-label, prospective, randomized, parallel-group comparison

Diabetes Obesity and Metabolism ◽

10.1111/dom.13557 ◽

2018 ◽

Vol 21 (3) ◽

pp. 710-714 ◽

Cited By ~ 5

Author(s):

Kyu Yong Cho ◽

Akinobu Nakamura ◽

Kazuno Omori ◽

Takahiro Takase ◽

Aika Miya ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Body Weight ◽

Group Comparison ◽

Open Label ◽

Related Factors ◽

Dapagliflozin Added to Glimepiride in Patients with Type 2 Diabetes Mellitus Sustains Glycemic Control and Weight Loss Over 48 Weeks: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial

Diabetes Therapy ◽

10.1007/s13300-014-0072-0 ◽

2014 ◽

Vol 5 (1) ◽

pp. 267-283 ◽

Cited By ~ 45

Author(s):

Krzysztof Strojek ◽

Kun-Ho Yoon ◽

Veronika Hruba ◽

Jennifer Sugg ◽

Anna Maria Langkilde ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Weight Loss ◽

Glycemic Control ◽

Controlled Trial ◽

Double Blind ◽

Diacylglycerol-induced improvement of whole-body insulin sensitivity in type 2 diabetes mellitus: A long-term randomized, double-blind controlled study

Clinical Nutrition ◽

10.1016/j.clnu.2008.01.009 ◽

2008 ◽

Vol 27 (2) ◽

pp. 203-211 ◽

Cited By ~ 20

Author(s):

Duo Li ◽

Tongcheng Xu ◽

Hideto Takase ◽

Ichiro Tokimitsu ◽

Pianhong Zhang ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Insulin Sensitivity ◽

Whole Body ◽

Controlled Study ◽

Double Blind